-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Introduction to the main features of the in vivo tumor experimental platform
Author:
InnoModels
Release time:
2024-04-12
In the field of biomedicine, tumor research has always been an important topic for researchers. With the development of science and technology, experimental platforms are constantly upgraded to meet the needs of more accurate and faster research. The in vivo tumor experimental platform of InnoModels Biotechnology is one of the leaders, which leads the new direction of tumor research with its unique features.
1. Highly accurate simulation
The most important feature of InnoModels' in vivo tumor platform is its ability to simulate the complexity of tumors in the human body with a high degree of accuracy. Although traditional in vitro experiments can provide a certain amount of research data, due to the lack of complexity and dynamics of the in vivo environment, the research results are often difficult to fully reflect the real situation. By simulating the in vivo environment, the in vivo tumor experimental platform of InnoModels Biotechnology can more realistically reflect the process of tumor growth and metastasis, and provide more reliable data and results for researchers.
2. Accelerate drug development
Drug development is one of the important directions of tumor research. The traditional drug development process is often time-consuming and has a low success rate. The in vivo tumor experimental platform of InnoModels Biotechnology provides new possibilities for drug development. Researchers can utilize this platform to evaluate the effectiveness and safety of drugs more quickly, thus accelerating the drug development process. This not only improves the efficiency of drug development, but also brings earlier treatment opportunities for patients.

3、Support multidisciplinary research
InnoModels' in vivo tumor platform is not only suitable for basic research, but also widely used in clinical research and translational medicine. The platform supports multidisciplinary collaboration, allowing researchers to study tumors from different perspectives and at different levels. This interdisciplinary research approach helps to discover new treatment methods and approaches and promote the in-depth development of tumor research.
4、Forward-looking technology application
InnoModels Bio's in vivo tumor experimental platform adopts a series of forward-looking technology applications, such as bio-3D printing technology, biosensor technology, etc. These technologies make the experimental process more efficient. The application of these technologies makes the experimental process more precise and controllable, and at the same time provides researchers with more experimental means and data acquisition methods. The application of these technologies not only improves the experimental efficiency, but also brings new breakthroughs for tumor research.
5、Safety and ethical protection
In the process of tumor experiments, safety and ethical issues have always been of great concern. The in vivo tumor experimental platform of InnoModels Biotechnology has fully considered these issues at the beginning of its design. The platform adopts strict operational and ethical standards to ensure the safety and compliance of the experimental process. At the same time, the platform also focuses on animal welfare and ethical issues to minimize pain and harm to animals. This great attention to safety and ethics has earned the in vivo tumor experiment platform of InnoModels Biotechnology a good reputation in the industry.
6. Summary
With its highly accurate simulation, accelerated drug development, support for multidisciplinary research, and forward-looking technology application, the InnoModels Biotechnology in vivo tumor experimental platform has become an important tool in the field of tumor research. Its appearance not only improves the efficiency and accuracy of tumor research, but also provides new research ideas and methods for researchers. In the future, with the continuous progress and development of science and technology, the in vivo tumor experimental platform of InnoModels Biotechnology is expected to play a greater role in the field of tumor research and make a greater contribution to the health of mankind.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd